Add to MyYahoo RSS

Biotech News

Biotech news continually updated from thousands of sources around the net.

30 min ago | Investor's Business Daily

United Therapeutics Legal Victory Sends Stock Flying

United Therapeutics stock soared to an all-time of 118 on the victory. In midday trading in the stock market today , United Therapeutics was up nearly 26%, near 115.50.


Related Topix: United Therapeutics, Medicine, Healthcare Industry

4 hrs ago | Investor's Business Daily

4 Biotechs That Might Be Bought Soon

While IBD has no greater ability than anyone else to predict the future, here are four biotech stocks that have been named as possible targets on the Street, with stock-moving results.


Related Topix: Medicine, Healthcare Industry, InterMune, Financial Markets

7 hrs ago |

Friday's ETF Movers: XBI, PIZ

Our mission at Market News Video is to produce and distribute quality online videos about the stock markets and publicly traded companies.


Related Topix: United Therapeutics, Medicine, Healthcare Industry, Arrowhead Research, Financial Markets

Fri Aug 29, 2014

Fox News

AstraZeneca boosted by start of new cancer drug trial

Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer.


Related Topix: Oncology, Medicine, Pfizer, Healthcare Industry


Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk

Takeda Pharmaceuticals and Eli Lilly & Co lost a bid to overthrow a combined $9 billion punitive-damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.


Related Topix: Medicine, Eli Lilly, Healthcare Industry, Actos, Pioglitazone (generic), Diabetes, Health

CombiMatrix CFO Buys $2,040 in Stock

CombiMatrix CFO Scott R. Burell acquired 1,000 shares of the company's stock on the open market in a transaction that occurred on Wednesday, August 27th.


Related Topix: CombiMatrix, Healthcare Industry

Business Journal

Medifast adopts 'poison pill' to ward off takeover attempts

Weight-loss company Medifast, which makes products like Garlic Mashed Potatoes and Sour Cream and Chive Mashed Potatoes, announced a stockholder rights plan Thursday, Aug. 28. Medifast Inc. has moved to put a stockholder rights plan or "poison pill" in place that would make it hard for an outside company to execute a hostile takeover.


Related Topix: Medicine, Medifast, Healthcare Industry, Potatoes, Life, Food, Vegetables

Medical News

FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

Mylan Inc. today announced that its abbreviated new drug application for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration .


Related Topix: Food and Drug Administration, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Dey, Startups

Frustrating Boston Scientific Is Not What the Investor Ordered

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.


Related Topix: Mozilla, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Thu Aug 28, 2014


Paging Dr. Watson, IBM's medical adviser for the future

IBM continues to make the case for the nascent field of cognitive computing, showing off some Watson prototypes Thursday that could help speed scientific discovery in the medical field, by scanning large volumes of literature and data far more quickly then humans can, and suggesting possible leads.


Related Topix: Healthcare Law, Law, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry


Regional crisis talks as Ebola death toll tops 1,500

Ebola-hit nations met for crisis talks on Thursday as the death toll topped 1,500 and the World Health Organization warned that the number of cases could exceed 20,000 before the outbreak is stemmed.


Related Topix: Nigeria, World News, Africa, GlaxoSmithKline, Epidemic, Natural Disasters, Liberia, Sierra Leone

Scientists dig into Ebola's deadly genes for clues

This undated handout photo provided by the journal Science shows Ebola surveillance at Kenema Governement Hospital is done by polymerase chain reaction, or PCR.


Related Topix: National Institutes of Health, Medicine, Healthcare Industry, Harvard University, Sierra Leone, World News, Africa

WAPT-TV Jackson

Experimental Ebola vaccine trial starts soon

A highly anticipated test of an experimental Ebola vaccine will begin next week at the National Institutes of Health, amid mounting anxiety about the spread of the deadly outbreak in West Africa.


Related Topix: Medicine, Food and Drug Administration, Infectious Diseases, GlaxoSmithKline, Genetics

Service sector firms have helped boost Oxfordshire recovery

The county's economy grew by 3.5 per cent last year, compared with the national rate of 3.2 per cent, making it the second-best-performing area in the south east.


Related Topix: Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Outsourcing

PhysOrg Weblog

Ebola vaccine trials being fast-tracked: researchers

Safety trials on an Ebola vaccine are being fast-tracked, meaning it could be given to healthy volunteers as early as September, researchers said Thursday.


Related Topix: Medicine, GlaxoSmithKline, Healthcare Industry

Business Journal

AmeriSource Bergen to add 185 jobs, expand into Conshohocken

AmerisourceBergen will expand its local operations by leasing and renovating Millennium III, an existing 70,000-square-foot office building in Conshohocken, and has committed to add 185 new jobs in the Philadelphia region over the next three years, Pennsylvania Gov. Tom Corbett said.


Related Topix: AmerisourceBergen, Conshohocken, PA, US Governors, Tom Corbett, Chesterbrook, PA

Wed Aug 27, 2014


InterMune drug may offer big upside to Roche if aimed at liver

Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.


Related Topix: InterMune, Medicine, Healthcare Industry, Health, Fibrosis, Food and Drug Administration

Business Journal

ModusLink takes 10 percent stake in Medifast

A supply chain and logistics company has taken a nearly 10 percent stake in Medifast over the last month - and left open the door to buying more.


Related Topix: Medicine, Medifast, Healthcare Industry


Ebola virus

A Centers for Disease Control and Prevention staff member has returned to the United States from West Africa by charter flight after the employee had low-risk contact with a health worker who tested positive for Ebola.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry


Should you buy ISIS? No, not that one

You might think that a company called Isis Pharmaceuticals would be itching to change its name in order to avoid confusion with the terrorist organization Islamic State of Iraq and Syria .


Related Topix: Isis Pharmaceuticals, Medicine, Healthcare Industry, Startups, Facebook, Social Software, Twitter


Biotech Jobs